Information

Japan's Chinese Medicine Research Association member store owner visits

Japan's Chinese Medicine Research Association member store owner visits

2018-03-30
In the spring of March of Yangchun, with its bright sunshine and flourishing flowers, the company ushered in a visit by members of the Japan Society of Chinese Medicine Research. The company paid grea
Tottori Shimagen Japan Society of Traditional Chinese Medicine visited our company

Tottori Shimagen Japan Society of Traditional Chinese Medicine visited our company

2016-09-22
Just after the Mid-Autumn Festival, Huaxing Pharmaceutical Co., Ltd. visited the guests. At 10 o'clock in the morning on September 19th, a delegation of 7 people from the Japanese Society of Tradition
The company carries out the “Mind Aggregation Smelting Team” Winter Expansion Campaign

The company carries out the “Mind Aggregation Smelting Team” Winter Expansion Campaign

2017-02-20
On the eve of New Year's Day in 2017, our company has organized winter development activities. This is the first time the company has planned and organized its own expansion activities. Through this s
New imported workshop equipment

New imported workshop equipment

2017-05-25
In early May, the code scanning equipment purchased from Japan entered the workshop, which will play an important role in improving the quality of product packaging. It will also greatly reduce the wo
Chinese medicine generic name naming technology guidelines

Chinese medicine generic name naming technology guidelines

2018-05-22
On November 28, the State Food and Drug Administration issued the "Circular on Publishing Guiding Principles for the Universal Naming of Chinese Patented Drugs," and issued a "Circular on Regulating t
Drug Administration to take the lead, the ex-factory price of drugs can be traced back across the country

Drug Administration to take the lead, the ex-factory price of drugs can be traced back across the country

2018-05-22
On March 20th, 2017, the reporter learned from the informed sources that the policy of information on the ex-factory price of pharmaceuticals that was brewed for one year is expected to be formally in